On the one hand, ZFHX4 could be used to predict occurrence of metastasis in ovarian cancer patients, especially for those have completed therapy and were undergoing follow-up; On the other hand, the expression of ZFHX4 is prognostic for survival outcomes of ovarian cancer patients with metastasis. This evidence concerns the gene ZFHX4 and ovarian carcinoma.